Journal of Cancer Research and Therapeutics Close
 

Figure 3: Forest plot of relative risk of serious adverse events associated with molecular target anticancer drugs versus control in subgroup analysis

Figure 3: Forest plot of relative risk of serious adverse events associated with molecular target anticancer drugs versus control in subgroup analysis